Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
Authors
Keywords
-
Journal
NATURE NEUROSCIENCE
Volume 25, Issue 1, Pages 39-49
Publisher
Springer Science and Business Media LLC
Online
2021-12-10
DOI
10.1038/s41593-021-00971-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural equilibrium underlying ligand-dependent activation of β2-adrenoreceptor
- (2020) Shunsuke Imai et al. Nature Chemical Biology
- TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
- (2020) Reid H. J. Olsen et al. Nature Chemical Biology
- Structure of a D2 dopamine receptor–G-protein complex in a lipid membrane
- (2020) Jie Yin et al. NATURE
- Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
- (2020) Kuglae Kim et al. CELL
- Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
- (2019) Kanako Terakado Kimura et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
- (2019) Stephen J. Kaar et al. NEUROPHARMACOLOGY
- Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole
- (2019) Carmen Klein Herenbrink et al. ACS Chemical Biology
- KAMO: towards automated data processing for microcrystals
- (2018) Keitaro Yamashita et al. Acta Crystallographica Section D-Structural Biology
- Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
- (2018) Sheng Wang et al. NATURE
- Aminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
- (2018) Márton Vass et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serotonin and brain function: a tale of two receptors
- (2017) RL Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
- (2017) John D McCorvy et al. Nature Chemical Biology
- The influence of the glutamatergic system on cognition in schizophrenia: A systematic review
- (2017) Elizabeth H.X. Thomas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists
- (2016) Xin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
- (2015) Wesley K Kroeze et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice
- (2015) Pelin Tanyeri et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
- (2015) Wesley K Kroeze et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT6 and Dopamine D2 Receptor Ligands.
- (2014) Niels Krogsgaard-Larsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clozapine, a Fast-Off-D2 Antipsychotic
- (2013) Philip Seeman ACS Chemical Neuroscience
- Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography
- (2013) James Foadi et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Molecular signatures of G-protein-coupled receptors
- (2013) A. J. Venkatakrishnan et al. NATURE
- Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists
- (2012) Xin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Automated design of ligands to polypharmacological profiles
- (2012) Jérémy Besnard et al. NATURE
- Serotonin 2A receptor antagonists for treatment of schizophrenia
- (2011) Bjørn H Ebdrup et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
- (2011) J. A. Allen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integration, scaling, space-group assignment and post-refinement
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models
- (2010) Sridhar Natesan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- Crystallizing membrane proteins using lipidic mesophases
- (2009) Martin Caffrey et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started